{"web_url": "http://www.nytimes.com/2016/01/14/business/hemophilia-patient-or-drug-seller-dual-role-creates-ethical-quandary.html", "snippet": "When hemophiliacs make their living by selling lucrative hemophilia drugs, patient advocates say it creates a dangerous conflict of interest.", "multimedia": [{"height": 126, "subtype": "wide", "url": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbWide.jpg", "width": 190, "type": "image", "legacy": {"wideheight": "126", "wide": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbWide.jpg", "widewidth": "190"}}, {"height": 398, "subtype": "xlarge", "url": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-articleLarge.jpg", "width": 600, "type": "image", "legacy": {"xlarge": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-articleLarge.jpg", "xlargeheight": "398", "xlargewidth": "600"}}, {"height": 75, "subtype": "thumbnail", "url": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbStandard.jpg", "width": 75, "type": "image", "legacy": {"thumbnail": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}}], "byline": {"original": "By ANDREW POLLACK", "person": [{"organization": "", "firstname": "Andrew", "lastname": "POLLACK", "rank": 1, "role": "reported"}]}, "lead_paragraph": "When hemophiliacs make their living by selling lucrative hemophilia drugs, patient advocates say it creates a dangerous conflict of interest.", "abstract": "Increasing number of hemophilia drug makers and specialty pharmacies are employing patients and their relatives to gain sales advantage and increase revenue; ethical issues are raised. ", "keywords": [{"is_major": "Y", "rank": "1", "name": "subject", "value": "Hemophilia"}, {"is_major": "N", "rank": "11", "name": "organizations", "value": "Novo Nordisk A/S"}, {"is_major": "N", "rank": "12", "name": "organizations", "value": "Baxalta Inc."}, {"is_major": "Y", "rank": "2", "name": "subject", "value": "Drugs (Pharmaceuticals)"}, {"is_major": "Y", "rank": "3", "name": "subject", "value": "Conflicts of Interest"}, {"is_major": "N", "rank": "4", "name": "subject", "value": "Blood"}, {"is_major": "N", "rank": "5", "name": "subject", "value": "Ethics and Official Misconduct"}, {"is_major": "N", "rank": "6", "name": "organizations", "value": "Hemophilia of North Carolina"}, {"is_major": "N", "rank": "7", "name": "organizations", "value": "National Hemophilia Foundation"}, {"is_major": "N", "rank": "8", "name": "organizations", "value": "MedfusionRx LLC"}, {"is_major": "N", "rank": "9", "name": "organizations", "value": "Bayer AG"}, {"is_major": "N", "rank": "10", "name": "organizations", "value": "Pfizer Inc"}], "section_name": "Business Day", "blog": [], "_id": "569694b938f0d865e6c34836", "slideshow_credits": null, "pub_date": "2016-01-14T00:00:00Z", "type_of_material": "News", "print_page": "1", "subsection_name": null, "source": "The New York Times", "word_count": "1254", "document_type": "article", "news_desk": "Business", "headline": {"print_headline": "The Patient&#8217;s Sales Pitch ", "main": "Hemophilia Patient or Drug Seller? Dual Role Creates Ethical Quandary"}}